Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Taisei Wake"'
Autor:
Iori Tanahashi, Takafumi Shiganami, Takayuki Iwayama, Taisei Wake, Sayaka Kobayashi, Haruo Yoshimasu
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 2, Pp 166-173 (2022)
Abstract Aim To investigate the association between psychotropic prescriptions and the total amount of psychotropics ingested during a subsequent intentional overdose and to examine factors related to the number of psychotropic prescriptions. Methods
Externí odkaz:
https://doaj.org/article/6e3b51e9d474448181371116bc4e7868
Autor:
Kei Funaki, Hajime Tabuchi, Masahiro Jinzaki, Masaru Mimura, Koji Murakami, Takahito Yoshizaki, Yoshihiro Noda, Tadaki Nakahara, Daisuke Ito, Bun Yamagata, Masashi Kameyama, Shinichiro Nakajima, Taisei Wake
Publikováno v:
Psychogeriatrics. 19:325-332
Background Subjective cognitive decline (SCD) may herald the first symptoms of Alzheimer's disease (AD) whereas individuals with beta-amyloid (Aβ) deposition are regarded as a high-risk group for AD. Recently, amyloid positron emission tomography (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae2d289b6c1f63adff1d02aa644d3564
https://doi.org/10.1111/psyg.12397
https://doi.org/10.1111/psyg.12397
Autor:
Kei Funaki, Daisuke Ito, Iori Tanahashi, Takahito Yoshizaki, Hajime Tabuchi, Tadaki Nakahara, Hiroumi Shimazaki, Taisei Wake, Masahiro Jinzaki, Masaru Mimura, Haruo Yoshimasu, Bun Yamagata
Publikováno v:
American journal of Alzheimer's disease and other dementias. 35
This study aimed to investigate the long-term impacts of disclosing amyloid status for a risk of Alzheimer disease (AD) to cognitively normal research participants with subjective cognitive decline (SCD), which represents an initial manifestation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d931ad1e53e5b5df27b09f3c9d64beb
https://pubmed.ncbi.nlm.nih.gov/32052640
https://pubmed.ncbi.nlm.nih.gov/32052640
Autor:
Taisei Wake, Takahito Yoshizaki, Kei Funaki, Daisuke Ito, Koji Murakami, Masaru Mimura, Hajime Tabuchi, Tadaki Nakahara, Masashi Kameyama, Masahiro Jinzaki, Bun Yamagata
Publikováno v:
International Psychogeriatrics. 30:635-639
In Japan, 4.6 million people are living with dementia and the number is expected to rise to 7 million by 2025. Amyloid-β (Aβ) positron emission tomography (PET) is used for cognitively normal Japanese people with or without subjective cognitive dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a814af473f3801701c3fdb4ec6b02cb
https://doi.org/10.1017/s1041610217002204
https://doi.org/10.1017/s1041610217002204
Autor:
Yuka Kudo, Teruo Nojima, Atsuo Nakagawa, Natsumi Ishikawa, Masaru Mimura, Taisei Wake, Mizuki Nakahara, Chika Kurata
Publikováno v:
Neuropsychiatric Disease and Treatment
Yuka Kudo,1,2 Atsuo Nakagawa,1,3 Taisei Wake,1 Natsumi Ishikawa,1 Chika Kurata,1 Mizuki Nakahara,4 Teruo Nojima,2 Masaru Mimura1 1Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, 2Department of Psychiatry, Gunma Hospital, Gun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f5777c553920d2bd03fece1d28089a
https://doi.org/10.2147/ndt.s123788
https://doi.org/10.2147/ndt.s123788
Autor:
Kei, Funaki, Shinichiro, Nakajima, Yoshihiro, Noda, Taisei, Wake, Daisuke, Ito, Bun, Yamagata, Takahito, Yoshizaki, Masashi, Kameyama, Tadaki, Nakahara, Koji, Murakami, Masahiro, Jinzaki, Masaru, Mimura, Hajime, Tabuchi
Publikováno v:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 19(4)
Subjective cognitive decline (SCD) may herald the first symptoms of Alzheimer's disease (AD) whereas individuals with beta-amyloid (Aβ) deposition are regarded as a high-risk group for AD. Recently, amyloid positron emission tomography (PET) studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ca1014e54519e7bfe7e41b47b77cefe
https://pubmed.ncbi.nlm.nih.gov/30688000
https://pubmed.ncbi.nlm.nih.gov/30688000
Autor:
Tadaki Nakahara, Iori Tanahashi, Daisuke Ito, Masahiro Jinzaki, Hiroumi Shimazaki, Koji Murakami, Kei Funaki, Bun Yamagata, Masaru Mimura, Takahito Yoshizaki, Haruo Yoshimasu, Taisei Wake, Hajime Tabuchi, Masashi Kameyama
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8db21ff45c6e6a7e23a9847431ac077a
https://doi.org/10.1016/j.jalz.2018.07.205
https://doi.org/10.1016/j.jalz.2018.07.205
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3818846c8fe19fe43f031d384bd65d45
https://doi.org/10.1016/j.jalz.2016.07.125
https://doi.org/10.1016/j.jalz.2016.07.125
Autor:
Yuka Kudo, Atsuo Nakagawa, Taisei Wake, Natsumi Ishikawa, Chika Kurata, Mizuki Nakahara, Teruo Nojima, Masaru Mimura
Publikováno v:
Neuropsychiatric Disease & Treatment; Jan2017, Vol. 13, p17-24, 8p